undefined undefined
NaN.000
NaN.00%
HC Wainwright & Co.:维持Apollomics(APLM.US)评级,由买入调整至买入评级, 目标价由5.00美元调整至2.00美元。
05-09 03:20
12月31日,冠科美博(APLM.US)公布财报,公告显示公司2023财年净利润为-1.73亿美元,同比增加28.22%;其中营业收入为--,每股基本收益为-...
03-29 14:16
Apollomics press release (NASDAQ:APLM): FY GAAP EPS of -$2.32. Apollomics (APLM) had $37.8 million in cash, cash equivalents and money market funds as of December 31, 2023, with a cash runway through ...
03-28 20:42
Apollomics (NASDAQ:APLM) reported quarterly losses of $(2.32) per share. This is a 72.51 percent increase over losses of $(8.44) per share from the same period last year.
03-28 19:06
喜讯! 北燃蓝天获得首笔可持续发展挂钩贷款 近日,北京燃气蓝天控股有限公司 (下称 “北燃蓝天” 或 “公司”) 首笔可持续发展挂钩贷款 (下称...
03-21 18:09
Treatment of NSCLC patients with MetExon14 skipping mutation with and without c...
2023-12-04 08:00
Coinbase盘前回调逾1%;中概股盘前小幅走弱,3倍做空富时中国ETF跌超3%,理想、小鹏均跌超1%>>
2023-11-27 17:48
Apollomics Inc's (NASDAQ: APLM) partner in China, Avistone Biotechnology Co.
2023-11-16 23:03